Shareholders’ Equity (Deficit)
 9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Shareholders’ Equity (Deficit) Shareholders’ Equity (Deficit)
Under the Company’s Amended and Restated Memorandum of Association and Articles of Association, or Articles, in effect as of September 30, 2023 and December 31, 2022, the Company had authorized an unlimited number of common shares with no par value.
As of September 30, 2023 and December 31, 2022, 26,213,504 and 24,815,908 common shares, respectively, were issued and 25,805,434 and 24,407,838 common shares, respectively, were outstanding.
During the nine months ended September 30, 2023, the Company granted stock options and RSUs to employees and contractors (see Note 8).
On April 27, 2023, the Company issued 1,100,000 common shares in an underwritten public offering, at a price to the public of $71.50 per share. The underwriters purchased the shares from the Company at a price of $67.21 per share and exercised the option to purchase additional 165,000 common shares, at the public offering price per share. Net proceeds to the Company after deducting underwriting discounts and offering expenses were approximately $84.6 million.
The Company had reserved common shares for future issuances as follows:
September 30,
2023
December 31, 2022
Options to purchase common shares1,815,802 1,873,165 
Remaining shares available under the 2018 Equity Incentive Plan2,886,433 2,271,999 
Shares issuable on vesting of grants of RSUs222,573 164,643 
Remaining shares available under the 2018 ESPP1,035,000 848,000 
Total5,959,808 5,157,807